Idbiologics, Inc.
Clinical trials sponsored by Idbiologics, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug combo IDB-011 tested for safety against rift valley fever Results expected Oct 2026 (estimated)